MRI特征可预测颅内胶质瘤的1p/19q状态
本研究回顾性评估69例经病理科记录确认曾行1p/19q检测的II或III级胶质瘤患者的术前MRI,由2名不知晓1p/19q状态的神经放射科医生盲法评估13项MR特征。验证队列中放射科医生对1p/19q状态总体预测的一致性为85%,准确率为84%。>50% T2-FLAIR不匹配对非共缺失肿瘤的特异度为100%,钙化对1p/19q共缺失肿瘤的特异度为97%。
要点
- >50% T2-FLAIR不匹配对识别非共缺失肿瘤特异度达100%(P=.001)。
- 钙化提示1p/19q共缺失肿瘤,特异度97%(P=.006)。
- 无法行正式1p/19q检测时,MRI-组织学联合评估可能提高诊断准确率。
核心结论
- >50% T2-FLAIR不匹配高度预测非共缺失肿瘤,钙化提示1p/19q共缺失肿瘤;若无法行正式1p/19q检测,MRI-组织学联合评估可能优于单独组织学。
研究设计与样本
- 回顾性研究,通过病理科记录确定既往行1p/19q检测的患者,69例符合纳入标准,术前MRI由2名不知晓1p/19q状态的神经放射科医生盲法评估13项MR特征,先在10例初始小队列评估特征后缩小标准用于其余患者作为验证队列。
关键影像表现/征象
- >50% T2-FLAIR不匹配见于14个肿瘤,对识别非共缺失肿瘤特异度100%(P=.001),观察者间相关性97%。
- 钙化见于7个肿瘤,其中6个为1p/19q共缺失(特异度97%,P=.006),观察者间相关性100%。
诊断标准与关键数值
- 验证队列中放射科医生对1p/19q状态总体预测的一致性为85%,准确率84%。
- >50% T2-FLAIR不匹配识别非共缺失肿瘤:特异度100%(P=.001)。
- 钙化识别1p/19q共缺失肿瘤:特异度97%(P=.006)。
临床应用与阅片要点
- 阅片时注意评估T2-FLAIR不匹配程度是否超过50%,该征象高度预测非共缺失肿瘤。
- 发现钙化时提示肿瘤可能为1p/19q共缺失。
- 若正式1p/19q检测不可行,作者认为MRI-组织学联合评估可能提高诊断准确率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The 2016 revision of the World Health Organization Classification of Tumors of the Central Nervous System mandates codeletion of chromosomes 1p and 19q for the diagnosis of oligodendroglioma. We studied whether conventional MR imaging features could predict 1p/19q status.
MATERIALS AND METHODS: Patients with previous 1p/19q testing were identified through pathology department records, typically performed on the basis of an oligodendroglial component on routine histology; 69 patients met the inclusion criteria. Preoperative imaging of patients with grade II or III gliomas was retrospectively assessed by 2 neuroradiologists, blinded to the 1p/19q status. Thirteen MR imaging features were first assessed in a small initial cohort (n = 10), after which the criteria were narrowed for the remaining patients as a validation cohort.
RESULTS: There was 85% agreement between radiologists for the overall prediction of 1p/19q status in the validation cohort, with an accuracy of 84%. The presence of >50% T2-FLAIR mismatch and calcification was found to be the most useful for predicting 1p/19q status. The >50% T2-FLAIR mismatch variable was demonstrated in 14 tumors and had 100% specificity for identifying a noncodeleted tumor (P = .001), with 97% interobserver correlation. Calcification was visualized in 7 tumors, 6 of which were 1p/19q codeleted (specificity, 97%; P = .006), with 100% interobserver correlation.
CONCLUSIONS: The presence of >50% T2-FLAIR mismatch is highly predictive of a noncodeleted tumor, while calcifications suggest a 1p/19q codeleted tumor. If formal 1p/19q testing is not possible, a combined MR imaging-histologic assessment may improve the diagnostic accuracy over histology alone.
引用
- Lasocki A, Gaillard F, Gorelik A, et al. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas. AJNR Am J Neuroradiol. 2018. PMID: 29519793. doi:10.3174/ajnr.A5572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。